Coffee After Pancreatic Surgery

NCT ID: NCT04205058

Last Updated: 2019-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

199 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-05

Study Completion Date

2021-12-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Postoperative ileus is a common complication after major abdominal surgery. A positive effect of coffee to bowel movement has been described after colorectal and gynecologic interventions. The objective of this randomised controlled trial is to investigate whether the implementation of a fast track protocol with early coffee consumption accelerates the recovery of bowel function after pancreaticoduodenectomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Postoperative ileus (POI) is a common disorder after major abdominal surgery, affecting up to 40% of patients undergoing laparotomy. POI is described as the time between surgery and the first passage of flatus and/or stool and tolerance of oral diet. It could be recognised as postoperative complication when is defined as two or more of nausea/vomiting, inability to tolerate oral diet over 24 h, absence of flatus over 24 h, abdominal distention and radiologic confirmation on or after day 4 postoperatively without prior resolution. Multimodal approaches have been described to treat POI; among them, the early consumption of coffee showed a substantial benefit after colorectal and gynecologic surgery. The objective of this randomised placebo-controlled trial is to investigate whether early coffee consumption can accelerate the recovery of bowel function after open pancreaticoduodenectomy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Ileus Postoperative Complications Bowel Dysfunction Pancreatic Diseases

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Randomised clinical trial Pancreatic surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

randomised placebo-controlled single blinded trial
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
Participants are masked about the type of coffee administrated (standard coffee versus caffeine-free coffee). Masking about administration of hot water is not feasible.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

standard coffee

Hot standard coffee with caffeine (one 30 mL espresso cup twice a day, from postoperative day one to first bowel movement or postoperative day three).

Group Type EXPERIMENTAL

Standard coffee

Intervention Type DIETARY_SUPPLEMENT

One 30 mL espresso cup administered twice a day (08.00 a.m. and 02.00 p.m.).

caffeine-free coffee

Hot caffeine-free coffee (one 30 mL espresso cup twice a day, from postoperative day one to first bowel movement or postoperative day three).

Group Type PLACEBO_COMPARATOR

Caffeine-free coffee

Intervention Type DIETARY_SUPPLEMENT

One 30 mL espresso cup administered twice a day (08.00 a.m. and 02.00 p.m.).

water

Hot water (one 30 mL espresso cup twice a day, from postoperative day one to first bowel movement or postoperative day three).

Group Type SHAM_COMPARATOR

Drinking water

Intervention Type DIETARY_SUPPLEMENT

One 30 mL espresso cup administered twice a day (08.00 a.m. and 02.00 p.m.).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard coffee

One 30 mL espresso cup administered twice a day (08.00 a.m. and 02.00 p.m.).

Intervention Type DIETARY_SUPPLEMENT

Caffeine-free coffee

One 30 mL espresso cup administered twice a day (08.00 a.m. and 02.00 p.m.).

Intervention Type DIETARY_SUPPLEMENT

Drinking water

One 30 mL espresso cup administered twice a day (08.00 a.m. and 02.00 p.m.).

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Elective open pancreaticoduodenectomy
* Age ≥ 18 years
* American Society Anesthesiologists (ASA) score ≤ 3
* Ability of the subject to understand aims and clinical consequences of the trial
* Written informed consent

Exclusion Criteria

* American Society Anesthesiologists (ASA) score ≥ 4
* Need for early postoperative Intensive Care Unit care
* Need for naso-gastric tube on postoperative day one
* Intolerance to coffee
* Refuse to assume coffee
* Pregnancy
* Surgical procedures performed different from pancreaticoduodenectomy
* Impaired mental status or language problems
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Azienda Ospedaliera Universitaria Integrata Verona

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Claudio Bassi, MD

Role: STUDY_DIRECTOR

Azienda Ospedaliera Universitaria Integrata Verona

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AOUI Verona

Verona, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Fabio Casciani, MD

Role: CONTACT

Phone: +39 045 8124553

Email: [email protected]

Erica Secchettin

Role: CONTACT

Phone: +39 045 8126254

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Erica Secchettin

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Lassen K, Coolsen MM, Slim K, Carli F, de Aguilar-Nascimento JE, Schafer M, Parks RW, Fearon KC, Lobo DN, Demartines N, Braga M, Ljungqvist O, Dejong CH; ERAS(R) Society; European Society for Clinical Nutrition and Metabolism; International Association for Surgical Metabolism and Nutrition. Guidelines for perioperative care for pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS(R)) Society recommendations. Clin Nutr. 2012 Dec;31(6):817-30. doi: 10.1016/j.clnu.2012.08.011. Epub 2012 Sep 26.

Reference Type BACKGROUND
PMID: 23079762 (View on PubMed)

Vather R, Trivedi S, Bissett I. Defining postoperative ileus: results of a systematic review and global survey. J Gastrointest Surg. 2013 May;17(5):962-72. doi: 10.1007/s11605-013-2148-y. Epub 2013 Feb 2.

Reference Type BACKGROUND
PMID: 23377782 (View on PubMed)

Artinyan A, Nunoo-Mensah JW, Balasubramaniam S, Gauderman J, Essani R, Gonzalez-Ruiz C, Kaiser AM, Beart RW Jr. Prolonged postoperative ileus-definition, risk factors, and predictors after surgery. World J Surg. 2008 Jul;32(7):1495-500. doi: 10.1007/s00268-008-9491-2.

Reference Type BACKGROUND
PMID: 18305994 (View on PubMed)

Story SK, Chamberlain RS. A comprehensive review of evidence-based strategies to prevent and treat postoperative ileus. Dig Surg. 2009;26(4):265-75. doi: 10.1159/000227765. Epub 2009 Jul 3.

Reference Type BACKGROUND
PMID: 19590205 (View on PubMed)

Asgeirsson T, El-Badawi KI, Mahmood A, Barletta J, Luchtefeld M, Senagore AJ. Postoperative ileus: it costs more than you expect. J Am Coll Surg. 2010 Feb;210(2):228-31. doi: 10.1016/j.jamcollsurg.2009.09.028. Epub 2009 Nov 18.

Reference Type BACKGROUND
PMID: 20113944 (View on PubMed)

Muller SA, Rahbari NN, Schneider F, Warschkow R, Simon T, von Frankenberg M, Bork U, Weitz J, Schmied BM, Buchler MW. Randomized clinical trial on the effect of coffee on postoperative ileus following elective colectomy. Br J Surg. 2012 Nov;99(11):1530-8. doi: 10.1002/bjs.8885. Epub 2012 Sep 14.

Reference Type BACKGROUND
PMID: 22987303 (View on PubMed)

Dulskas A, Klimovskij M, Vitkauskiene M, Samalavicius NE. Effect of Coffee on the Length of Postoperative Ileus After Elective Laparoscopic Left-Sided Colectomy: A Randomized, Prospective Single-Center Study. Dis Colon Rectum. 2015 Nov;58(11):1064-9. doi: 10.1097/DCR.0000000000000449.

Reference Type BACKGROUND
PMID: 26445179 (View on PubMed)

Gungorduk K, Ozdemir IA, Gungorduk O, Gulseren V, Gokcu M, Sanci M. Effects of coffee consumption on gut recovery after surgery of gynecological cancer patients: a randomized controlled trial. Am J Obstet Gynecol. 2017 Feb;216(2):145.e1-145.e7. doi: 10.1016/j.ajog.2016.10.019. Epub 2016 Oct 22.

Reference Type BACKGROUND
PMID: 27780709 (View on PubMed)

Hasler-Gehrer S, Linecker M, Keerl A, Slieker J, Descloux A, Rosenberg R, Seifert B, Nocito A. Does Coffee Intake Reduce Postoperative Ileus After Laparoscopic Elective Colorectal Surgery? A Prospective, Randomized Controlled Study: The Coffee Study. Dis Colon Rectum. 2019 Aug;62(8):997-1004. doi: 10.1097/DCR.0000000000001405.

Reference Type BACKGROUND
PMID: 30998528 (View on PubMed)

Bassi C, Molinari E, Malleo G, Crippa S, Butturini G, Salvia R, Talamini G, Pederzoli P. Early versus late drain removal after standard pancreatic resections: results of a prospective randomized trial. Ann Surg. 2010 Aug;252(2):207-14. doi: 10.1097/SLA.0b013e3181e61e88.

Reference Type BACKGROUND
PMID: 20622661 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2296CESC

Identifier Type: -

Identifier Source: org_study_id